Johnson & Johnson’s new Covid-19 Vaccine awaits approval and it is important to look at the coding and billing ahead of time. New vaccine CPT codes have been released for the vaccine and staying up to date will keep you in best practice once the vaccine is distributed. Read below to get the full story. nnAs new COVID-19 vaccines continue to be approved and distributed it is important to make sure you are correctly coding, and billing based on the vaccine given.nAhead of the approval of the new Johnson and Johnson COVID-19 vaccine, the AMA has added a new CPT code 91303 (Severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] [COVID-19] vaccine, DNA, spike protein, adenovirus type 26 [Ad26] vector, preservative free, 5×1010 viral particles/0.5 mL dosage, for intramuscular use).nnIn addition to this new vaccine code, there is also a new HCPCS code 0031A (Immunization administration by intramuscular injection of SARS-CoV-2 [COVID-19] vaccine, DNA, spike protein, Ad26 vector, preservative free, 5×1010 viral particles/0.5 mL dosage, single dose) for administration.nnThis code will take affect immediately following approval of the vaccine by the Food and Drug Administration (FDA). As of this writing, it is still pending approval.
